透景生命：累计回购约29万股

Company Summary - Tuojing Life announced a share buyback of approximately 290,000 shares, accounting for 0.18% of the company's total share capital, with a total expenditure of approximately RMB 8.15 million [1] - The highest and lowest prices for the repurchased shares were RMB 29.34 and RMB 27.3 per share, respectively [1] - As of the report, Tuojing Life's market capitalization stands at RMB 4.4 billion [1] Industry Summary - For the fiscal year 2024, Tuojing Life's revenue is entirely derived from the in vitro diagnostics industry, with a 100% contribution from this sector [1]